Make Informed Investment Decisions with Affordable Access to Experts
A 2nd View: Looking at Evolus' DWP-450 (PrabotulinumtoxinA) purified botulinum toxin in treating glabellar (frown) linesTicker(s): EOLS, RVNC, AGN
Name: Dr David Kahn - MD
- Clinical Associate Professor Plastic Surgery, Section Chief- Cosmetic Surgery, Division of Plastic Surgery at Stanford.
- Personally does all his own injections and injects between 20 and 50 patients with Botox a month.
- Mixed cosmetic and reconstructive practice with both surgical and non surgical treatments.
Please describe your clinical practice; roughly how many patients do you currently treat with injectables for glabellar lines?Added By: c_admin
What are your initial thoughts on DWP-450 (PrabotulinumtoxinA)? If approved how likely would you be to switch patients off Botox?Added By: c_admin
On a scale from 1-10, 10 being extremely excited, where would you rate your level of excitement for this drug?Added By: c_admin
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.